Role of IL-6 and IL-1b in immune dysfunction during aging, HIV, and HCV infection

IL-6 和 IL-1b 在衰老、HIV 和 HCV 感染期间免疫功能障碍中的作用

基本信息

项目摘要

Chronic systemic inflammation is associated with immune dysfunction and morbidities in the elderly, treated HIV infection, and HCV infection. We propose that circulating inflammatory proteins drive immune exhaustion and senescence and contribute to the immune dysfunction seen in these patient groups. Nearly 4 million Americans are infected with Hepatitis C Virus (HCV) and the mean age of US veterans infected with HCV is nearing 65 years. Although the new IFN-free direct-acting antiviral therapy is highly effective at clearing virus from patients, the patients are left with the consequences of decades of infection and liver damage, and it is still unclear how long soluble mediators of inflammation persist, and how long immune dysfunction and associated morbidity lasts. Similarly, even HIV-infected patients that have successfully controlled viral replication with ART for decades have increased mortality and morbidity and persistent inflammation. The VA is the largest single provider of HIV care in the US. Understanding what causes the continued morbidity in these veteran patient populations is critical. The elderly, HCV and HIV-infected patients all have chronic immune inflammation and these three patient groups share many of the same comorbidities including cardiovascular disease, cancer, and liver disease. The project design of this CDA-2 application is based on the understanding that patients with chronic viral infections and elderly patients show chronic elevated plasma levels of IL-6, and our more recent data demonstrating elevated levels of IL-1β in lymph nodes of HIV-infected patients. The central goals of this study are to determine the underlying mechanisms of IL-6 and IL-1β that contribute to the development of immune exhaustion and senescence and to examine the potential therapeutic role of temporarily blocking IL-6 and IL-1β during chronic infection to improve immune function and recovery of exhausted or senescent T cells. The hypothesis that chronic elevated levels of IL-6 and IL-1β during aging, HCV infection and HIV infection contribute to immune senescence and exhaustion and resulting immune dysfunction will be tested in 3 specific Aims. Aim 1 will determine the phenotype and function of T cells that have been exposed to IL-1β or IL-6 in vitro by sorting the cells positive for exhaustion or senescent markers (PD-1, CD57, Tim-3, KLRG1, Lag3) and examining their functional abilities to determine if inflammatory cytokines alone can drive senescence, independent of antigen exposure. Aim 2A will examine the expression levels of exhaustion and senescent markers and the intracellular production of cytokines associated with the senescence-associated secretory phenotype (SASP) in lymphocytess from HCV-infected, treated HIV-infected, and elderly patients by flow cytometry. Aim 2B will examine the recovery and normalization of immune function, longitudinally, in HIV-infected patients after initiation of ART and in HCV-infected patients after initiation of IFN-free direct-acting antiviral therapy. In Aim 3 we will use a mouse model of chronic viral infection (LCMV) to determine the effect of late blockade of IL-6 and IL-1β on the development of exhausted and senescent T cells, and the recovery of T cell function and proliferative ability. The candidate's long term goals are to understand the effects of chronic inflammation on health, the mechanisms by which the immune system maintains homeostasis, and how inflammation disrupts the ability of the immune system to reestablish homeostasis after infection and during aging. This focus supports a growing need nationwide to advance our understanding and develop therapeutic strategies in the aging veteran population with and without chronic viral infection. The candidate's career goals are to use this Career Development Award to successfully transition to an independent investigator at the Louis Stokes Cleveland VAMC, and to establish a productive, thriving, national leading research program in the VA system.
慢性全身炎症与老年人的免疫功能障碍和发病有关,接受治疗 HIV感染和HCV感染。我们认为循环炎症蛋白会导致免疫衰竭 和衰老,并导致这些患者群体中出现的免疫功能障碍。近400万 美国人感染丙型肝炎病毒(HCV),感染HCV的美国退伍军人的平均年龄是 已近65岁。尽管新的无干扰素直接作用抗病毒疗法在清除病毒方面非常有效 从患者身上,患者留下了数十年感染和肝损伤的后果,这是 仍不清楚可溶性炎症介质持续多久,以及免疫功能障碍和 相关的发病率持续存在。同样,即使是已成功控制病毒的艾滋病毒感染者 几十年来 ART 的复制增加了死亡率和发病率以及持续性炎症。弗吉尼亚州 是美国最大的艾滋病毒护理单一提供者。了解导致持续发病的原因 这些经验丰富的患者群体至关重要。老年人、HCV和HIV感染者都患有慢性病 免疫炎症和这三个患者组有许多相同的合并症,包括 心血管疾病、癌症和肝脏疾病。该 CDA-2 应用程序的项目设计基于 了解慢性病毒感染患者和老年患者的血浆长期升高 IL-6 水平,以及我们最新的数据表明 HIV 感染者淋巴结中 IL-1β 水平升高 患者。本研究的中心目标是确定 IL-6 和 IL-1β 的潜在机制 有助于免疫衰竭和衰老的发展,并检查潜在的治疗方法 慢性感染期间暂时阻断IL-6和IL-1β对改善免疫功能和恢复的作用 耗尽或衰老的 T 细胞。假设衰老过程中 IL-6 和 IL-1β 水平长期升高, HCV 感染和 HIV 感染会导致免疫衰老和衰竭,从而导致免疫 功能障碍将在 3 个特定目标中进行测试。目标 1 将确定 T 细胞的表型和功能 通过对衰竭或衰老标记物呈阳性的细胞进行分选,在体外暴露于 IL-1β 或 IL-6 (PD-1、CD57、Tim-3、KLRG1、Lag3)并检查它们的功能能力以确定是否存在炎症 细胞因子本身就可以驱动衰老,与抗原暴露无关。目标 2A 将检查表达式 疲劳和衰老标志物的水平以及与细胞因子相关的细胞内产生 HCV 感染、HIV 感染治疗的淋巴细胞中的衰老相关分泌表型 (SASP) 和老年患者通过流式细胞术。目标 2B 将检查免疫的恢复和正常化 纵向功能,在开始 ART 后的 HIV 感染患者和在开始 ART 后的 HCV 感染患者中 开始无干扰素直接作用抗病毒治疗。在目标 3 中,我们将使用慢性病毒感染小鼠模型 感染(LCMV)以确定后期阻断 IL-6 和 IL-1β 对衰竭发展的影响 和衰老的T细胞,以及T细胞功能和增殖能力的恢复。候选人的长期 目标是了解慢性炎症对健康的影响、免疫系统的机制 系统维持体内平衡,以及炎症如何破坏免疫系统重建的能力 感染后和衰老过程中的稳态。这一重点支持全国范围内不断增长的需求,以推进我们的 了解并制定患有或不患有慢性病毒的老年退伍军人群体的治疗策略 感染。候选人的职业目标是利用此职业发展奖成功过渡到 路易斯·斯托克斯克利夫兰 VAMC 的独立调查员,并建立一个富有成效、蓬勃发展、 VA 系统的国家领先研究计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carey Lynn Shive其他文献

Carey Lynn Shive的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carey Lynn Shive', 18)}}的其他基金

Impact of preexisting immune profile in elderly on influenza vaccine response
老年人原有免疫特征对流感疫苗反应的影响
  • 批准号:
    10485431
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
COVID19: Respiratory SARS-CoV-2 seroprevalence and the association of humoral immune responses with clinical outcomes in veterans and employees in the Cleveland VA Medical Center
COVID19:克利夫兰退伍军人医疗中心退伍军人和员工的呼吸道 SARS-CoV-2 血清流行率以及体液免疫反应与临床结果的关联
  • 批准号:
    10160554
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
COVID19: Respiratory SARS-CoV-2 seroprevalence and the association of humoral immune responses with clinical outcomes in veterans and employees in the Cleveland VA Medical Center
COVID19:克利夫兰退伍军人医疗中心退伍军人和员工的呼吸道 SARS-CoV-2 血清流行率以及体液免疫反应与临床结果的关联
  • 批准号:
    10359116
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Role of IL-6 and IL-1b in immune dysfunction during aging, HIV, and HCV infection
IL-6 和 IL-1b 在衰老、HIV 和 HCV 感染期间免疫功能障碍中的作用
  • 批准号:
    10291768
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了